These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38682764)

  • 1. Autoimmune encephalitis mediated by postvaccination and infection of SARS-CoV-2 in a patient with a narcolepsy type 1.
    Peraita-Adrados R; Bravo-Quelle N
    Rev Neurol; 2024 May; 78(9):265-268. PubMed ID: 38682764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
    Valencia Sanchez C; Theel E; Binnicker M; Toledano M; McKeon A
    Neurology; 2021 Dec; 97(23):e2262-e2268. PubMed ID: 34635560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Autoimmune Encephalitis Following COVID-19 Infection.
    Hilado M; Banh M; Homans J; Partikian A
    J Child Neurol; 2022 Mar; 37(4):268-272. PubMed ID: 35014889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune Encephalitis Concomitant with SARS-CoV-2 Infection: Insight from
    Grimaldi S; Lagarde S; Harlé JR; Boucraut J; Guedj E
    J Nucl Med; 2020 Dec; 61(12):1726-1729. PubMed ID: 32709734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Corticosteroid Responsive Meningoencephalitis with Cerebral Vasculitis after COVID-19 Infection in a Thirteen-Year-Old.
    François G; Cleuziou P; Vannod-Michel Q; Derambure P; Nguyen-The-Tich S; Chaton L
    Neuropediatrics; 2023 Feb; 54(1):68-72. PubMed ID: 35817356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute encephalitis after COVID-19 vaccination: A case report and literature review.
    Gao JJ; Tseng HP; Lin CL; Hsu RF; Lee MH; Liu CH
    Hum Vaccin Immunother; 2022 Nov; 18(5):2082206. PubMed ID: 35700455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    Vuille-Lessard É; Montani M; Bosch J; Semmo N
    J Autoimmun; 2021 Sep; 123():102710. PubMed ID: 34332438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
    Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
    J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection.
    Nguyen TD; Mall G; Westphal JG; Weingärtner O; Möbius-Winkler S; Schulze PC
    ESC Heart Fail; 2021 Dec; 8(6):4710-4714. PubMed ID: 34536056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible neurological and brain MRI changes following COVID-19 vaccination: A case report.
    Rastogi A; Bingeliene A; Strafella AP; Tang-Wai DF; Wu PE; Mandell DM
    J Neuroradiol; 2022 Nov; 49(6):428-430. PubMed ID: 35381296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Yassine HM; Benslimane FM; Al Khatib HA; Tang P; Hasan MR; Coyle P; Al Kanaani Z; Al Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Al Kuwari MG; Butt AA; Al Romaihi HE; Al-Thani MH; Al Khal A; Bertollini R
    JAMA; 2021 Nov; 326(19):1930-1939. PubMed ID: 34724027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series.
    Kaulen LD; Doubrovinskaia S; Mooshage C; Jordan B; Purrucker J; Haubner C; Seliger C; Lorenz HM; Nagel S; Wildemann B; Bendszus M; Wick W; Schönenberger S
    Eur J Neurol; 2022 Feb; 29(2):555-563. PubMed ID: 34668274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
    Chung H; He S; Nasreen S; Sundaram ME; Buchan SA; Wilson SE; Chen B; Calzavara A; Fell DB; Austin PC; Wilson K; Schwartz KL; Brown KA; Gubbay JB; Basta NE; Mahmud SM; Righolt CH; Svenson LW; MacDonald SE; Janjua NZ; Tadrous M; Kwong JC;
    BMJ; 2021 Aug; 374():n1943. PubMed ID: 34417165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.